Arne Blickle

Change in total lesion PSMA (TLP) during [177Lu]Lu-PSMA-617 radioligand therapy predicts overall survival in patients with mCRPC: monocentric evaluation of a prospective registry

A. Schaefer-Schuler, M. Bartholomä, S. Maus, 2023, European journal of nuclear medicine and molecular imaging.

Ectopic Cushing Syndrome Localized by 68Ga-DOTA-LM3 PET/CT.

F. Rosar, S. Ezziddin, Arne Blickle, 2024, Clinical nuclear medicine.

Analysis of Molecular Imaging and Laboratory Baseline Biomarkers in PSMA-RLT: Whole-Body Total Lesion PSMA (TLP) Predicts Overall Survival

A. Schaefer-Schuler, M. Hoffmann, F. Rosar, 2024, Cancers.

225Ac-PSMA-617 Augmentation in High-Risk mCRPC Undergoing 177Lu-PSMA-617 Radioligand Therapy

A. Schaefer-Schuler, M. Bartholomä, F. Rosar, 2024, Clinical nuclear medicine.

Change of glucometabolic activity per PSMA expression predicts survival in mCRPC patients non-responding to PSMA radioligand therapy: introducing a novel dual imaging biomarker

A. Schaefer-Schuler, M. Bartholomä, S. Maus, 2024, Frontiers in medicine.